ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -97.8% | 1,650 | -98.8% | 0.00% | – |
| Q1 2022 | $90,000 | -40.0% | 137,945 | 0.0% | 0.00% | – |
| Q4 2021 | $150,000 | -40.5% | 137,945 | -0.2% | 0.00% | – |
| Q3 2021 | $252,000 | -46.2% | 138,218 | -22.0% | 0.00% | – |
| Q2 2021 | $468,000 | -25.9% | 177,286 | +1.0% | 0.00% | -100.0% |
| Q1 2021 | $632,000 | +56.4% | 175,500 | +9.5% | 0.00% | – |
| Q4 2020 | $404,000 | -17.9% | 160,300 | -17.9% | 0.00% | -100.0% |
| Q3 2020 | $492,000 | -23.1% | 195,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $640,000 | +83.9% | 195,200 | +37.4% | 0.00% | 0.0% |
| Q1 2020 | $348,000 | -48.1% | 142,100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $671,000 | -5.2% | 142,100 | -14.1% | 0.00% | 0.0% |
| Q3 2019 | $708,000 | -26.1% | 165,500 | +0.7% | 0.00% | 0.0% |
| Q2 2019 | $958,000 | +97.1% | 164,300 | +30.1% | 0.00% | 0.0% |
| Q1 2019 | $486,000 | +105.9% | 126,300 | 0.0% | 0.00% | – |
| Q4 2018 | $236,000 | -41.6% | 126,300 | 0.0% | 0.00% | – |
| Q3 2018 | $404,000 | +6.0% | 126,300 | 0.0% | 0.00% | – |
| Q2 2018 | $381,000 | -23.0% | 126,300 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $495,000 | -5.4% | 126,300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $523,000 | -32.5% | 126,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $775,000 | -12.7% | 126,300 | -11.5% | 0.00% | 0.0% |
| Q2 2017 | $888,000 | -1.9% | 142,790 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $905,000 | +32.1% | 142,791 | +11.5% | 0.00% | 0.0% |
| Q4 2016 | $685,000 | +10.3% | 128,100 | +16.1% | 0.00% | 0.0% |
| Q3 2016 | $621,000 | +2.5% | 110,300 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $606,000 | -25.9% | 110,300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $818,000 | -10.8% | 110,300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $917,000 | -7.7% | 110,300 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $994,000 | -26.6% | 110,300 | -2.3% | 0.00% | 0.0% |
| Q2 2015 | $1,355,000 | – | 112,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |